65 related articles for article (PubMed ID: 2289150)
1. MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors.
Lowy MT
Brain Res; 1990 Nov; 533(2):348-52. PubMed ID: 2289150
[TBL] [Abstract][Full Text] [Related]
2. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum.
Muraki A; Koyama T; Nakayama M; Ohmori T; Yamashita I
Neurosci Lett; 1992 Feb; 136(1):39-42. PubMed ID: 1353257
[TBL] [Abstract][Full Text] [Related]
3. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
Farfel GM; Vosmer GL; Seiden LS
Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
[TBL] [Abstract][Full Text] [Related]
6. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
Muraki A
Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization.
Ohno M; Yoshida H; Watanabe S
Brain Res; 1994 Nov; 665(1):135-40. PubMed ID: 7882006
[TBL] [Abstract][Full Text] [Related]
9. Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
Fuller RW; Hemrick-Luecke SK; Ornstein PL
Neuropharmacology; 1992 Oct; 31(10):1027-32. PubMed ID: 1436384
[TBL] [Abstract][Full Text] [Related]
10. MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow.
O'Dell SJ; Weihmuller FB; Marshall JF
Ann N Y Acad Sci; 1992 May; 648():317-9. PubMed ID: 1637061
[No Abstract] [Full Text] [Related]
11. The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
Miller DB; O'Callaghan JP
Ann N Y Acad Sci; 1993 May; 679():321-4. PubMed ID: 8099774
[No Abstract] [Full Text] [Related]
12. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
13. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats.
Lowy MT
Neuroendocrinology; 1990 Feb; 51(2):190-6. PubMed ID: 2154717
[TBL] [Abstract][Full Text] [Related]
14. In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.
Massari CM; Castro AA; Dal-Cim T; Lanznaster D; Tasca CI
Toxicol In Vitro; 2016 Dec; 37():162-168. PubMed ID: 27647473
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study.
Pu C; Vorhees CV
Synapse; 1995 Feb; 19(2):97-104. PubMed ID: 7725247
[TBL] [Abstract][Full Text] [Related]
16. Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices.
Bowyer JF; Scallet AC; Holson RR; Lipe GW; Slikker W; Ali SF
J Pharmacol Exp Ther; 1991 Apr; 257(1):262-70. PubMed ID: 1673475
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.
Smith KJ; Self RL; Butler TR; Mullins MM; Ghayoumi L; Holley RC; Littleton JM; Prendergast MA
Brain Res; 2007 Jul; 1157():74-80. PubMed ID: 17524372
[TBL] [Abstract][Full Text] [Related]
18. Effect of dizocilpine maleate on discriminative properties of methamphetamine in rats.
Liang JC; Zheng IW
Acta Pharmacol Sin; 2000 Jul; 21(7):605-8. PubMed ID: 11360666
[TBL] [Abstract][Full Text] [Related]
19. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study.
Weihmuller FB; O'Dell SJ; Cole BN; Marshall JF
Brain Res; 1991 May; 549(2):230-5. PubMed ID: 1884217
[TBL] [Abstract][Full Text] [Related]
20. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
Robinson S; Krentz L; Moore C; Meshul CK
Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
